Adjuvant intraportal venous chemotherapy for patients with hepatocellular carcinoma and portal vein tumor thrombi following hepatectomy plus portal thrombectomy

World Journal of Surgery

Volumn 32, Issue 4, 2008, Pages 627-631

  Liang, Li Jian ^a   Hu, Wen Jie ^a   Yin, Xiao Yu ^a   Zhou, Qi ^a   Peng, Bao Gang ^a   Li, Dong Ming ^a   Lu, Ming De ^a  

^a SUN YAT SEN UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; CISPLATIN; DOXORUBICIN; FLUOROURACIL; RECOMBINANT ALPHA INTERFERON;

ADULT; ALOPECIA; ARTICLE; CANCER CHEMOTHERAPY; CANCER PATIENT; CANCER SURVIVAL; CONTROLLED STUDY; DRUG FEVER; FEMALE; HUMAN; LEUKOPENIA; LIVER CELL CARCINOMA; LIVER RESECTION; MAJOR CLINICAL STUDY; MALE; PERITONITIS; PORTAL VEIN BLOOD FLOW; PORTAL VEIN THROMBOSIS; PROGNOSIS; SURVIVAL RATE; THROMBECTOMY; UNSPECIFIED SIDE EFFECT;

ADULT; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CARCINOMA, HEPATOCELLULAR; CHEMOTHERAPY, ADJUVANT; CISPLATIN; COMBINED MODALITY THERAPY; DOXORUBICIN; FEMALE; FLUOROURACIL; HEPATECTOMY; HUMANS; INTERFERON ALFA-2B; LIVER NEOPLASMS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; NEOPLASM INVASIVENESS; PORTAL VEIN; RISK FACTORS; SURVIVAL RATE; THROMBECTOMY; VENOUS THROMBOSIS;

EID: 41049109174     PISSN: 03642313     EISSN: 14322323     Source Type: Journal    
DOI: 10.1007/s00268-007-9364-0     Document Type: Article

References (21)

1. Liver Cancer Study Group of Japan (1990) Primary liver cancer in Japan: clinicopathologic features and results of surgical treatment. Ann Surg 211:277-287
2. Llovet JM, Bru C, Bruix J (1999) Prognosis of hepatocellular carcinoma: The BCLC staging classification. Semin Liver Dis 19:329-338
3. Ikai I, Hatano E, Hasegawa S, et al. (2006) Prognostic index for patients with hepatocellular carcinoma combined with tumor thrombosis in the major portal vein. J Am Coll Surg 202:431-438
4. Niguma T, Mimura T, Tutui N (2005) Adjuvant arterial infusion chemotherapy after resection of hepatlcellular carcinoma with portal thrombosis: a pilot study. J Hepatobiliary Pancreat Surg 12:249-253
5. Pawlik TM, Poon RT, Abdalla EK, et al. (2005) Hepatectomy for hepatocellular carcinoma with major portal or hepatic vein invasion: results of a multicenter study. Surgery 137:403-410
6. Fan J, Zhou J, Wu ZQ, et al. (2005) Efficacy of different treatment strategies for hepatocellular carcinoma with portal vein tumor thrombosis. World J Gastroenterol 11:1215-1219
7. Fujioka N, Arivasu T, Arai N, et al. (2006) Role of p53 in the inhibitory effects of interferon-alpha subtypes on proliferation of hepatocellular carcinoma cells. Biomed Res 27:219-226
8. Oie S, Ono M, Yano H, et al. (2006) The up-regulation of type I interferon receptor gene plays a key role in hepatocellular carcinoma cells in the synergistic antiproliferative effect by 5-fluorouracil and interferon-alpha. Int J Oncol 29:1469-1478
9. Koike K, Takaki A, Tatsukawa M, et al. (2006) Combination of 5-FU and IFNalpha enhances IFN signaling pathway and caspase-8 activity, resulting in marked apoptosis in hepatoma cell lines. Int J Oncol 29:1253-1261
10. Leung TW, Tang AM, Zee B, et al. (2002) Factors predicting response and survival in 149 patients with unresectable hepatocellular carcinoma treated by combination cisplatin, interferon-alpha, doxorubicin and 5-fluorouracil chemotherapy. Cancer 94:421-427
11. Yin XY, Lu MD, Liang LJ, et al. (2005) Systemic chemo-immunotherapy for advanced-stage hepatocellular carcinoma. World J Gastroenterol 11:2526-2529
12. Leung TW, Patt YZ, Lau WY, et al. (1999) Complete pathological remission is possible with systemic combination chemotherapy for inoperable hepatocellular carcinoma. Clin Cancer Res 5:1676-1681
13. Edmonson HA, Steiner PE (1954) Primary carcinoma of the liver. a study of 100 cases among 48,900 necropsies. Cancer 7:462-503
14. Bruix J, Llovet JM (2002) Prognostic predictin and treatment strategy in hepatocellular carcinoma. Hepatology 35:519-524
15. Okada S, Okazaki N, Nose H, et al. (1992) Prognostic factors in patients with hepatocellular carcinoma receiving systemic chemotherapy. Hepatology 16:112-117
16. Raoul JL, Guyader D, Bretagne JE, et al. (1994) Randomized controlled trial for hepatocellular carcinoma with portal vein thrombosis: intra-arterial iodine-131-iodized oil versus medical support. J Nucl Med 35:1782-1787
17. Calvet X, Bruix J, Gines P, et al. (1990) Prognostic factors of hepatocellular carcinoma in the West: a multivariate analysis in 206 patients. Hepatology 12:753-760
18. Akashi Y, Koreeda C, Enomoto S, et al. (1991) Prognosis of unrectable hepatocellular carcinoma: an evaluation based on multivariate analysis of 90 cases. Hepatology 14:262-268
19. Yamaoka Y, Kumada K, Ino K, et al. (1992) Liver resection for HCC with direct remove of tumor thrombi in the main portal vein. World J Surg 16:1172-1176
20. Konishi M, Ryu M, Kinoshita T, et al. (2001) Surgical treatment of hepatocellular carcinoma with direct removal of the tumor thrombus in the main portal vein. Hepatogastroenterology 48:1421-1424
21. Zhou J, Tang ZY, Wu ZQ, et al. (2006) Factors influencing survival in hepatocellular carcinoma patients with macroscopic portal vein tumor thrombosis after surgery, with special reference to time dependency: a single-center experience of 381 cases. Hepatogastroenterology 53:275-280